Jim on Steve Kirsch's newsletter

[Jim]

Steve,

Here's another source for you:

Cosentino, M. and Marino, F., Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike? (September 17, 2022), Int. J. Mol. Sci. 2022, 23, 10881, at: https://www.mdpi.com/1422-0067/23/18/10881, wherein the authors state:

"Thus despite the EMA additional monitoring, taking Italy as a reference (and indeed it is, since it is constantly among the countries with the highest absolute number of COVID-19-vaccine-related reports included in the EudraVigilance system — https://www.adrreports.eu/ — accessed on 8 September 2022), the pharmacovigilance systems for these products are likely missing more than 999 adverse events of any severity per 1000 events, and more than 4998 severe adverse events per 5000 events."

This is a very good article written by a professor of pharmacology (Marco Cosentino (MD, PhD)) and colleague (Franca Marino (PhD)) at the University of Insubria, Italy. The URF estimate speaks to the COVID vaccines in particular. The review is very critical of the pharmacological steps that were skipped by the health regulatory authorities and of the overall regulatory approach taken, i.e., their review and approval as conventional vaccines, rather than as pharmacological products having multiple harmful ingredients (LNPs, pseudouridine, PEG, mRNAs, etc.), ultimately producing a harmful output (spike). Written by two pharmacology experts!

The Professor and research colleague may be well worth interviewing if you haven't already done so.

Thanks

Jim